Skip to content
healthcare.dev

Atracurium Besylate

NDC 0409-1105, ATRACURIUM BESYLATE, injection, solution, from Hospira, Inc..

Product NDC
0409-1105
Status
Listed
Labeler
Hospira, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090761
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0409-1105 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATRACURIUM BESYLATE10 mg/mL

Pharmacologic classes

Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]

Package NDCNDC-11Package
0409-1105-020040911050210 VIAL, MULTI-DOSE in 1 CARTON (0409-1105-02) / 10 mL in 1 VIAL, MULTI-DOSE (0409-1105-22)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/de1c2dcd-295b-47ce-b7a1-a8be59939a54

Use it

Look up 0409-1105 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0409-1105 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0409-1105. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.